THE STATE OF THE CORONARY BED IN CORONARY HEART DISEASE IN PATIENTS WITH HYPOTHYROIDISM
https://doi.org/10.57256/2949-0715-2023-4-64-71
Abstract
Hypothyroidism is a significant aggravating factor for coronary heart disease (CHD). However, there are no practical recommendations for the management of this group to date. The main method of assessing the severity of coronary artery disease is a morphological assessment of the condition of the coronary arteries.
The aim. To carry out comparative assessment of clinical parameters, including the state of the coronary bed in patients with coronary artery disease with newly diagnosed (without hormone replacement therapy) and primary manifest hypothyroidism compared with patients with coronary artery disease without hypothyroidism.
Materials and methods. Two hundred and forty patients with CHD were examined. The study group included 90 patients with coronary heart disease and hypothyroidism, the comparison group consisted of 150 patients with coronary artery disease without thyroid pathology. A comprehensive examination of patients, including coronary angiography, was performed. The frequency of cases and characteristics of lesions of the coronary bed, the volume of interventions were assessed. The analysis of the obtained data was carried out in Statistica 10.0 (StatSoft Inc., USA).
Results. In the study group (CHD and hypothyroidism), a statistically significantly increased level of myoglobin, a change in lipid profile parameters in relation to patients with CHD without hypothyroidism was found. In the group of patients with coronary artery disease and hypothyroidism, a predominance of the frequency of multivessel lesions of the coronary bed was revealed. The volume of surgical interventions between the examined patients did not reveal significant differences.
Conclusion. Patients with coronary heart disease and hypothyroidism should be considered as a group of additional cardiovascular risk and require a more careful approach. It is possible to prescribe higher dosages of statins.
About the Authors
Muneer Abdul Rahman
Department of Cardiology of the Karelian Institute of Medical Sciences, correspondence graduate student (applicant), Irkutsk State Medical University
India
India
Aleksey N. Sumin
Research Institute of Complex Problems of Cardiovascular Diseases
Russian Federation
Russian Federation
Andrey S. Ankudinov
Irkutsk State Medical University
Russian Federation
Russian Federation
References
1. Townsend N, Wilson L, Bhatnagar P et al. Cardiovascular disease in Europe: epidemiological update. Eur Heart J. 2016;37(42):3232‒3245. DOI:10.1093/eurheartj/ehw334
2. Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407-477. DOI:10.1093/eurheartj/ehz425
3. Triggiani V, Angelo Giagulli V, De Pergola G et al. Mechanisms Explaining the Influence of Subclinical Hypothyroidism on the Onset and Progression of Chronic Heart Failure. Endocr Metab Immune Disord Drug Targets. 2016;16(1):2-7. DOI:10.2174/1871530316666151218151319
4. Delitala AP, Scuteri A, Maioli M et al. Subclinical hypothyroidism and cardiovascular risk factors. Minerva Med. 2019;110(6):530-545. DOI:10.23736/S0026-4806.19.06292-X
5. Rastgooye Haghi A, Solhjoo M, Tavakoli MH. Correlation Between Subclinical Hypothyroidism and Dyslipidemia. Iran J Pathol. 2017;12(2):106-111. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831065/[accessed: 22.09.2023].
6. Cooper DS, Biondi B. Subclinical thyroid disease. Lancet. 2012;379(9821):1142-1154. DOI:10.1016/S0140-6736(11)60276-6
7. Gong N, Gao C, Chen X et al. Endothelial Function in Patients with Subclinical Hypothyroidism: A Meta-Analysis. Horm Metab Res. 2019;51(11):691-702. DOI:10.1055/a-1018-9564
8. Nair SN, Kumar H, Raveendran M, Menon VU. Subclinical Hypothyroidism and Cardiac Risk: Lessons from a South Indian Population Study. Indian J Endocrinol Metab. 2018;22(2):217-222. DOI:10.4103/ijem.IJEM_298_17
9. Zhou XZ, Shi R, Wang J, et al. Characteristics of coronary artery disease in patients with subclinical hypothyroidism: evaluation using coronary artery computed tomography angiography. BMC Cardiovasc Disord. 2021;21(1):303. DOI:10.1186/s12872-021-02116-0
10. Moon S, Kim MJ, Yu JM et al. Subclinical Hypothyroidism and the Risk of Cardiovascular Disease and All-Cause Mortality: A Meta-Analysis of Prospective Cohort Studies. Thyroid. 2018;28(9):1101-1110. DOI:10.1089/thy.2017.0414
11. Chubb SAP, Peters KE, Bruce DG, Davis WA, Davis TME. The relationship between thyroid dysfunction, cardiovascular morbidity and mortality in type 2 diabetes: The Fremantle Diabetes Study Phase II. Acta Diabetol. 2022;59(12):1615-1624. DOI:10.1007/s00592-022-01969-x
12. WMA Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects / 2013 World Medical Association. 64th WMA General Assembly, Fortaleza, Brazil, October 2013. https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects [accessed: 22.05.2023].
13. Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes [published correction appears in Eur Heart J. 2020 Nov 21;41(44):4242]. Eur Heart J. 2020;41(3):407-477. DOI:10.1093/eurheartj/ehz425
14. Фадеев В.В. По материалам клинических рекомендаций европейской тиреоидной ассоциации по использованию комбинированной терапии L-T4 + L-T3 в лечении гипотиреоза. Клиническая и экспериментальная тиреоидология. 2012; 8 (2): 14‒18. [Fadeev VV. Based on the clinical guidelines of the European Thyroid Association on the use of combination therapy L-T4 + L-T3 in the treatment of hypothyroidism. Clinical and experimental thyroidology. 2012;8(2):14‒18 (In Russian)]. DOI:10.14341/ket20128214-18
15. Реброва О.Ю. Статистический анализ медицинских данных. Применение пакета прикладных программ
16. STATISTICA. М.:МедиаСфера;2002. [Rebrova OYu. Statistical analysis of medical data. Application of the STATISTICA software package. Moscow:MediaSfera;2002. (In Russian)].
17. Delitala AP, Scuteri A, Maioli M et al. Subclinical hypothyroidism and cardiovascular risk factors. Minerva Med. 2019;110(6):530-545. DOI:10.23736/S0026-4806.19.06292-X
18. Treister-Goltzman Y, Yarza S, Peleg R. Lipid profile in mild subclinical hypothyroidism: systematic review and meta-analysis. Minerva Endocrinol (Torino). 2021;46(4):428-440. DOI:10.23736/S2724-6507.20.03197-1
Supplementary files
Review
For citations:
Rahman M., Sumin A., Ankudinov A. THE STATE OF THE CORONARY BED IN CORONARY HEART DISEASE IN PATIENTS WITH HYPOTHYROIDISM. Baikal Medical Journal. 2023;2(4):64-71. (In Russ.) https://doi.org/10.57256/2949-0715-2023-4-64-71
Views:
197
